Skip to content
10-Q/A

Quarterly Report

ASSURED PHARMACY, INC.

0001117768-13-000286

← back to feed
Filed
May 17, 2013 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · May 7, 2013 5.99M sh
Capex Q1 2013 · Mar 31, 2013 $37.33K
Capex Q1 2013 · Mar 31, 2012 $10.68K
Operating Cash Flow Q1 2013 · Mar 31, 2013 −$589.64K
Operating Cash Flow Q1 2013 · Mar 31, 2012 −$62.51K
Cash And Equivalents Q1 2013 · Mar 31, 2013 $11.79K
Cash And Equivalents Q1 2013 · Dec 31, 2012 $21.3K
Cash And Equivalents Q1 2013 · Mar 31, 2012 $6.51K
Cash And Equivalents Q1 2013 · Dec 31, 2011 $23.32K
Stockholders Equity Q1 2013 · Mar 31, 2013 −$7.23M
Stockholders Equity Q1 2013 · Dec 31, 2012 −$6.49M
Current Liabilities Q1 2013 · Mar 31, 2013 $8.24M
Current Liabilities Q1 2013 · Dec 31, 2012 $7.57M
Total Liabilities Q1 2013 · Mar 31, 2013 $9.56M
Total Liabilities Q1 2013 · Dec 31, 2012 $8.71M
Current Assets Q1 2013 · Mar 31, 2013 $1.35M
Current Assets Q1 2013 · Dec 31, 2012 $1.26M
Total Assets Q1 2013 · Mar 31, 2013 $2.33M
Total Assets Q1 2013 · Dec 31, 2012 $2.22M
Sga Expense restated Q1 2013 · Mar 31, 2013 $619.36K
Sga Expense Q1 2013 · Mar 31, 2012 $579.05K
Net Income restated Q1 2013 · Mar 31, 2013 −$1.13M
Net Income Q1 2013 · Mar 31, 2012 −$897.03K
Operating Income Q1 2013 · Mar 31, 2013 −$673.79K
Operating Income Q1 2013 · Mar 31, 2012 −$562.11K
Gross Profit restated Q1 2013 · Mar 31, 2013 $672.26K
Gross Profit Q1 2013 · Mar 31, 2012 $738.99K
Cost Of Revenue restated Q1 2013 · Mar 31, 2013 $2.22M
Cost Of Revenue Q1 2013 · Mar 31, 2012 $2.91M
Revenue restated Q1 2013 · Mar 31, 2013 $2.89M
Revenue Q1 2013 · Mar 31, 2012 $3.65M